Delivery Order SPE2DB20D1109-SPE2DB25FN99M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Pediarix HIB vaccine in 0.5ML vials, with a ceiling value of $1,938.38. This firm fixed price delivery order, which is due for completion by August 26, 2025, represents a competitively awarded non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Pediarix HB vaccine in 0.5 mL vials with a ceiling value of $1,137.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made on a competitive basis without any set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Pediarix (Hib) vaccine in 0.5 mL vials, with a ceiling value of $1,324.88 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.16 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution capabilities and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.10 on August 12, 2025, for the supply of Pediarix HIB vaccine in 0.5mL vials. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. This firm fixed price delivery order, valued at $1,252.15, carries an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.70 to AmerisourceBergen Drug Corp for the supply of Pediarix (PEDVAXHIB) vaccine in 0.5mL vials. The contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, operates under a firm fixed-price structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $4,949.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5mL vials. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this competitively awarded contract (no set-aside used) will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,115.70 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN99MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Pediarix/PedvaxHIB vaccine in 0.5 mL vials, with a ceiling value of $3,791.80 and an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pediatric immunization product delivery supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As one of the federal government's primary pharmaceutical distributors, AmerisourceBergen fulfills critical vaccine and medication needs across the Defense Health Agency and U.S. military healthcare systems. The company's extensive federal contract portfolio demonstrates its role as a major supplier of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 5/2/25 |